Alyeska Investment Group
CALC icon

Alyeska Investment Group’s CalciMedica CALC Stock Holding History

Alyeska Investment Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-372,256
Closed -$1.32M – 526
2024
Q4 		$1.32M Buy
+372,256
New +$1.3M 0.01% 484
2024
Q2 		– Sell
-75,082
Closed -$312K – 574
2024
Q1 		$312K Buy
+75,082
New +$343K ﹤0.01% 439
2021
Q1 		– Sell
-2,076
Closed -$843K – 744
2020
Q4 		$843K Sell
2,076
-3,324
-62% -$981K 0.01% 424
2020
Q3 		$961K Buy
+5,400
New +$1.13M 0.01% 391

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
WIA
Wealthedge Investment Advisors New York $272M AUM 10.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

Alyeska Investment Group's CALC Position: Q1 2025 in Review

Alyeska Investment Group sold out of CalciMedica (CALC) in Q1 2025, closing a stake of 372,256 shares — an estimated $1.32M sold.

Alyeska Investment Group first reported a position in CALC in Q3 2020 and held it in 4 quarters. The position peaked at $1.32M in Q4 2024. 30 funds tracked by Wall St. Rank hold CALC as of Q1 2025.

  • Alyeska Investment Group reported no remaining CalciMedica position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 372,256 CalciMedica shares in Q1 2025, an estimated $1.32M.
  • Alyeska Investment Group first reported a position in CalciMedica in Q3 2020 and held it in 4 quarters.
  • Alyeska Investment Group's CalciMedica position peaked at $1.32M in Q4 2024.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.